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Bone morphogenetic protein 4 (BMP4) is a potent growth factor that is involved in many important biological processes. Regulation of the level of secreted mature BMP4 determines the
biological effects of BMP4 on cells in the local microenvironment. Previous studies suggested that Gremlin, a member of
DAN family proteins, antagonizes BMP4 activity by sequestering extracellular BMP4. Herein, we report a novel intracellular
regulatory mechanism by which Gremlin interacts with BMP4
precursor, prevents secretion of mature BMP4, and therefore
inhibits BMP4 activity more efficiently. Furthermore, we also
defined a 30-amino acid peptide sequence within the Gremlin
DAN domain that is essential for BMP4 interaction. This novel
Gremlin-mediated BMP4 posttranslational regulatory mechanism implies that the level of BMP4 mRNA expression does not
truly reflect BMP4 activity when Gremlin and BMP4 are coexpressed within the same cell. Similar regulatory mechanisms
may be utilized by other DAN family proteins.

Bone morphogenetic protein 4 (BMP4)2 is a well studied
member of the BMP family (1), which plays an important role in
many organ developmental processes including the basic body
plan formation, the proximal-distal, left-right, and dorsal-ventral axes (2). BMP4 elicits different biological responses
depending upon the concentration of the secreted active form.
For example, at early embryonic stages, cells exposed to high
concentrations of BMP4 will commit to a ventral fate, while
cells exposed to low concentrations of active BMP4 will develop
into dorsal neural and muscular tissues (3, 4). Therefore, controlling both expression and activation of BMP4 is critical for
BMP4-mediated cell fate decision.
The expression and activity of BMP4 can be regulated at
multiple molecular levels, including transcriptional and post-

translational regulation. At the protein level, BMP4 is initially
synthesized as an inactive 50-kDa precursor protein within
cells. Dimerization of the BMP4 precursor protein occurs by
forming an intermolecular disulfide bond. Then, following proteolytic cleavage by members of the subtilisin-like proprotein
convertase family, an active carboxyl-terminal mature BMP4
protein dimer (25 kDa for the monomer) is produced, which is
then secreted outside the cell to act as a growth factor (5, 6, 7).
Furthermore, the secreted active BMP4 can also be inhibited at
the extracellular level by interacting with secreted BMP4 antagonists, such as noggin, chordin, Cer1, DAN, and Gremlin (8, 9,
10, 11).
Gremlin was originally identified as a molecule capable of
inducing secondary axis formation in the Xenopus embryo (12,
13). Recombinant Gremlin protein is known to bind mature
BMP2/4 in vitro and inhibits these BMP activities. A high level
of Gremlin expression is found in nondividing and terminally
differentiated cells such as neuron, alveolar epithelial cells, and
goblet cells (14). The phenotypes of mice with Gremlin null
mutation have shown that Gremlin plays an essential role in
limb, lung, and kidney development, possibly due to inappropriate BMP signaling during the respective organ development
(15, 16). However, the molecular mechanism of Gremlin-BMP4
interaction remains largely unexplored. Herein, we have found
that Gremlin can specifically bind to BMP4 precursor protein
inside cells, which prevents the production and secretion of
mature BMP4 protein and thus down-regulates BMP4 ligand
signaling in a most efficient manner. Thus, Gremlin functions
as a highly efficient intracellular BMP4 antagonist, in addition
to its classical extracellular antagonistic effect. Moreover, we
have also mapped the protein sequences in Gremlin that mediate BMP4-Gremlin interaction.
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Antibodies and Reagents—The antibodies to BMP4,
Gremlin, TGN38, and c-Myc epitope-tag antibodies were
purchased from Santa Cruz Biotechnology. Anti-HA
epitope-tag antibody was purchased from Covalence. Alexa
Fluor 594- or 488-labeled anti-mouse, anti-rabbit, and antigoat secondary antibodies were purchased from Invitrogen.
Human recombinant BMP4 was from R&D Systems. Short
peptides corresponding to the amino acid sequence of
mouse Gremlin 37–52 (DKAQHNDSEQTQSPPQ) and
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tured in the medium containing
10% fetal calf serum for 20 h and
then cultured in serum-free conditioned medium (CM) for additional
48 h prior to analysis. Experiments
were repeated at least three times.
Western Blot and Protein Co-immunoprecipitation—Equal amounts
of total cell lysate protein or CM
from different samples were separated in NuPAGE 4 –12% gradient
SDS-PAGE gels using a MOP buffering system (Invitrogen). After
protein was transferred into polyvinylidene difluoride membrane, proteins of interest were detected by
specific antibodies. Proteins in different subcellular compartments
were fractionated using the ProteoExtract subcellular proteome extraction kit (Calbiochem). The fractionation of cytosolic, membrane/
organelle, and nucleic proteins has
been confirmed as reported (17).
For co-immunoprecipitation experiments, cells were lysed at 4 °C in
Nonidet P-40 lysis buffer. Lysates
were cleared of insoluble material
by centrifugation, followed by incuFIGURE 1. Co-localization and interaction of BMP4 and Gremlin proteins in mouse fetal lung. A, E14.5 bation with Protein A/G-agarose
mouse fetal lung tissue was co-immunostained by goat anti-BMP4 and rabbit anti-Gremlin antibodies. B, beads (Santa Cruz Biotechnology).
endogenous Gremlin protein in tissues lysate was immunoprecipitated (IP) by anti-Gremlin antibody (Ab1 The supernatants of cell lysates
from Santa Cruz Biotechnology; Ab2 generated in our laboratory), and the co-precipitated BMP4 precursor
were then incubated with HA-speprotein was detected by immunoblot (IB) using anti-BMP4 antibody. NS, normal serum control.
cific antibody for 1 h, followed by
146 –175 (PKKFTTMMVTLNCPELQPPTKKKRVTRVKQ) further incubation with Protein A/G-agarose beads overnight
at 4 °C. The precipitated protein complexes were examined by
were synthesized by Genscript (Scotch Plains, NJ).
Plasmid Constructs—Myc-tagged mouse BMP4 cDNA Western blot.
Immunostaining—Co-immunofluorescence staining of
(Myc-BMP4) and HA-tagged mouse Gremlin cDNA (GREHA), as generated previously (7), were subcloned into pcDNA3 endogenous BMP4 and Gremlin was performed in E14.5
expression vector. The Myc epitope was inserted into the embryonic mouse lung using rabbit anti-Gremlin and goat anticarboxyl-terminal immediately adjacent to the cleavage site BMP4 antibodies. Co-localization of exogenously expressed
of mature BMP4, so that both precursor and mature forms of Myc-BMP4 and GRE-HA in cultured cells was detected by Myc
exogenously expressed BMP4 can be detected by Myc and HA epitope co-immunofluorescence staining under a Zeiss
epitope. Partial cDNA of mouse Mucin-2, which encodes a LSM510 confocal microscope with 400X optical magnification
Mucin-2 protein fragment of 114 amino acids on the car- and 4⫻ digital zoom.
Measurement of BMP4 Activity—BMP-stimulated mouse
boxyl terminus (PQNQ . . . LGRK, GenBankTM accession
number XP_620590), was generated by high fidelity RT-PCR myoblast C2C12 cell differentiation into osteoblast cells was
(Pfu, Stratagene) and verified by DNA sequencing. An HA used to measure BMP4 activity. Briefly, C2C12 cells were
epitope was also added to the carboxyl terminus of Mucin-2 grown in 96-well plate until 90% confluence. Agents (BMP4 or
by inverted PCR. Partial deletions of Gremlin and a variety of conditioned medium) were then added into the culture
Gremlin-Mucin-2 chimeric cDNA constructs were created medium (Dulbecco’s modified Eagle’s medium with 5% fetal
by inverted PCR in combination with restricted digestion bovine serum), and the cells were cultured for another 3 days.
The cells were then lysed with 0.1% Triton X-100, and the alkaand ligation of PCR products.
Cell Culture and Transient Transfection—COS-1 and C2C12 line phosphatase (ALP) activity in the cell lysate was quantified
cells (ATCC) were cultured in Dulbecco’s modified Eagle’s by adding substrate p-nitrophenyl phosphate and measuring
medium supplemented with 10% fetal calf serum at 37 °C in 5% A405. Triplicate measurements were always performed for each
CO2. Plasmid DNAs were transfected into the cells with Lipo- sample. For BMP4 inhibitory assay by Gremlin peptides, the
fectamine Plus (Invitrogen). The transfected cells were first cul- culture medium containing BMP4 (100 ng/ml) was preincu-
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bated with the related peptide at a concentration of 0.5 M for
3 h at 37 °C before added into C2C12 cells.

RESULTS
BMP4 Precursor Interacts with Gremlin Intracellularly in
Mouse Embryonic Lung—BMP4 gradient formation in tissue is
thought to be determined by extracellular interaction between
BMP4 and related antagonists. However, for cells that coexpress BMP4 and BMP antagonists, intracellular interaction
between BMP4 and BMP antagonists cannot be excluded. To
determine the interaction between Gremlin and BMP4, the
endogenous protein expression patterns of these two molecules
were first compared in developing lung, where both BMP4 and
Gremlin play important roles in its organogenesis (15, 16). By
co-immunofluorescence staining, Gremlin and BMP4 exhibited a partially overlapping epithelial expression pattern in
E14.5 mouse embryonic lung (Fig. 1A), suggesting the possibility that these two proteins could interact intracellularly. Therefore, physical interaction of endogenous Gremlin and BMP4
precursor inside cells was examined by co-immunoprecipitation in mouse fetal tissue lysate. As shown in Fig. 1B, a precursor form of BMP4 (50 kDa) was specifically co-immunoprecipitated with Gremlin protein in fetal mouse lung tissue lysate, but
not in kidney tissue, which suggested that tissue specific intracellular interaction between Gremlin and BMP4 precursor can
occur in vivo. The biological significance of intracellular Gremlin-BMP4 precursor protein interaction and related molecular
mechanisms were then further analyzed in cultured cells.
Intracellular Interaction of Gremlin-BMP4 Precursor Inhibits
BMP4 Activity Most Efficiently—Intracellular interaction of
BMP4 and Gremlin was further studied by coexpression of
these proteins in cultured C2C12 cells. Both HA epitope-tagged
Gremlin (GRE-HA) and Myc-epitope tagged BMP4 (MycBMP4) were co-localized in the cytoplasm of co-transfected
cells, as shown by co-immunofluorescence staining under a
confocal microscope (Fig. 2A). Furthermore, expressed MycBMP4 or GRE-HA was also co-localized with TGN38, a marker
for the trans-Golgi network (18), suggesting that both proteins
are trafficking through the same intracellular compartments
(Fig. 2B-2C). The subcellular localizations of Myc-BMP4 and
GRE-HA were also verified by Western blot detection in fractionated cell lysates (Fig. 2D). Expression of both Myc-BMP4
and GRE-HA was detected in the membrane/organelle protein
FIGURE 2. Subcellular localization and protein interaction of coexpressed
BMP4 and Gremlin. A–C, detection of protein expression in co-transfected
C2C12 cells under confocal microscope. Expression of Myc-BMP4 and GRE-HA
proteins overlaps in cytoplasm (A). Trans-Golgi marker TGN38 was also overlapped with either Myc-BMP4 (B) or GRE-HA (C ). Cell nuclei were counterstained by 4⬘,6-diamidino-2-phenylindole (blue color). D, subcellular localization of expressed Myc-BMP4 and GRE-HA was also determined by Western
blot detection in different subcellular fractions (Cy, cytosol; Me, membrane/
organelle; Nu, nuclei). E, BMP4 precursor protein, but not mature BMP4, was
specifically co-immunoprecipitated with Gremlin in co-transfected COS-1 cell
lysate. F, BMP4 activities in the conditioned media (CM) of COS-1 cells transfected with the indicated plasmids were evaluated by their stimulatory
effects on C2C12 cell differentiation into osteoblast cells, as measured by ALP
activity. (1), CM collected separately from the COS-1 cells transfected with
either Myc-BMP4 or GRE-HA were mixed and preincubated for 1 h before
added into C2C12 cells; (2), COS-1 cells transfected separately with either
Myc-BMP4 or GRE-HA were trypsinized and co-cultured during CM collection.
*, p ⬍ 0.05 as compared with the CM with BMP4 only.
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FIGURE 4. Gremlin DAN domain is essential for its BMP4 binding activity.
A, schematic diagram of truncated Gremlin molecules. B, co-immunoprecipitation of Myc-BMP4 with different mutant Gremlin molecules from co-transfected COS-1 cell lysate and CM was detected by Western blot.

FIGURE 3. Expression of Gremlin prevents mature BMP4 secretion from
co-transfected COS-1 cells. A, COS-1 cells were co-transfected with the indicated expression vectors, and the expressed GER-HA and Myc-BMP4 proteins
were detected in both cell lysate and concentrated CM with anti-HA and
anti-Myc antibodies, respectively. GRE-Muc-HA is a mutated Gremlin that
does not bind to BMP4. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) detection was used for protein loading control. B, the net activities of
BMP4 in the CM of the co-transfected cells were measured based on its effect
on C2C12 cell differentiation into osteoblast cells by adding equivalent
amount of CM into C2C12 cell culture medium. C, the same level of exogenous BMP4 mRNA was confirmed by Myc-tag-specific quantitative real-time
RT-PCR.

extract fraction (including endoplasmic reticulum and Golgi)
but not in the cytosolic and nucleic protein extract fractions.
The physical interaction between BMP4 and Gremlin proteins
in co-transfected COS-1 cells was then examined by protein
co-immunoprecipitation. Myc-BMP4 precursor in cell lysate,
but not mature Myc-BMP4 protein in conditioned medium
(CM), was co-immunoprecipitated with GRE-HA (Fig. 2E).
The activity of BMP4 secreted into CM was then measured
by its effect on myoblast C2C12 cell differentiation into osteoblasts (Fig. 2F), in which characteristic ALP is expressed and the
ALP level reflects BMP4 activity. The BMP4 activity in the CM
of Myc-BMP4 transfected cells was inhibited by 20 ⫾ 9% when
an equal amount of CM collected from GRE-HA transfected
cells was added. Interestingly, the CM collected from mixed
cells that had been transfected separately by either Myc-BMP4
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or GRE-HA exhibited a higher BMP4 inhibitory effect (55 ⫾
5%), possibly due to prolonged interaction between BMP4 and
Gremlin in the CM. However, BMP4 activity in the CM from
cells co-transfected with equal amounts of both GRE-HA and
Myc-BMP4 was even more markedly inhibited (86 ⫾ 4%, p ⬍
0.05), suggesting a more efficient inhibitory effect of intracellular Gremlin-BMP4 interaction than extracellular antagonistic
effect (Fig. 2F).
Intracellular Gremlin-BMP4 Precursor Interaction Prevents
Mature BMP4 Secretion—The precursor and mature forms of
BMP4 protein in transfected cell lysates and CM were further
analyzed. Consistent with previous reports (7), no mature
BMP4 was detected in the cell lysate, whereas mature but no
precursor BMP4 was detected in concentrated CM (Fig. 3A).
Most interestingly, reduced amounts of secreted mature BMP4
protein in CM were detected in inverse proportion to intracellular Gremlin expression (Fig. 3A). Therefore, lack of mature
BMP4 in the CM of co-transfected cells may explain that no
mature BMP4 was co-immunoprecipitated with Gremlin, as
shown above in Fig. 2E. The level of BMP4 precursor in cell
lysate was not significantly increased, even though BMP4 secretion was reduced, suggesting that BMP4-Gremlin complex may
subject to facilitated degradation to maintain the same level of
BMP4 precursor pool inside cell. Furthermore, both secreted
forms of Gremlin and mature Myc-BMP4 in CM were dramatically increased when coexpressed Gremlin was mutated to lose
its BMP4 binding activity (Gre-Muc-HA, see below for details),
while the level of mutated Gremlin was low in cell lysate. These
data suggest that intracellular interaction of Myc-BMP4 precursor and GRE-HA may prevent Myc-BMP4 precursor procVOLUME 281 • NUMBER 39 • SEPTEMBER 29, 2006
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FIGURE 5. Mapping BMP4-binding motif on Gremlin DAN domain. A, DAN domain protein sequences between Gremlin and Mucin-2 are aligned, and the
identical residues are highlighted in bold. The Cys residues for the knot structure are also depicted. B, a schematic diagram for a variety of Gremlin-Mucin-2
chimeras is illustrated. The result of BMP4-Gremlin co-immunoprecipitation in C is also summarized. C, co-immunoprecipitated Myc-BMP4 and Gremlin were
detected by Western blot using the related epitope antibodies. D, net activities of BMP4 in CM from transfected COS-1 cells were analyzed by their stimulatory
effects on osteoblast cell differentiation of C2C12 cells, as measured by ALP. The numbered Gremlin-Mucin-2 chimeras are indicated as shown in B. *, p ⬍ 0.05
as compared with the inhibitory activity of GRE-HA. E, addition of a synthetic peptide (0.5 M) corresponding to the mapped 30-amino acid sequence (145–174)
of the Gremlin DAN domain significantly inhibited BMP4 (100 ng/ml)-stimulated osteoblast cell differentiation of C2C12 cell line. Another synthetic peptide
with the amino acid sequence from the N-terminal fragment (37–52) of Gremlin was used as a negative control, and the CM of Gremlin-transfected COS-1 cells
was used as a positive control. *, p ⬍ 0.05 as compared with BMP4 ligand only.

essing and mature Myc-BMP4 secretion. The net BMP4 activities in the above CM were also quantified by the BMPstimulated C2C12 cell differentiation assay (Fig. 3B). The
SEPTEMBER 29, 2006 • VOLUME 281 • NUMBER 39

alterations of BMP4 activities in the CM were consistent with
changes in secreted BMP4 mature protein levels as detected by
Western blot in Fig. 3A. Moreover, transient Myc-BMP4 gene
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FIGURE 6. Structure modeling of Gremlin DAN domain. a, the ribbon structure of Gremlin DAN domain (amino acids 94 –184) is predicted by homology
modeling using the program Modeler version 8.1 (28), based on the published structure of human chorionic gonadotropin chain B (27). ␤-Strand is represented
as yellow-colored arrow. b and c, filled structure of the finger 2 in Gremlin DAN domain is viewed from the side (b) and the top (c) for the protein interface. Atoms
are colored as white for carbon, red for oxygen, and blue for nitrogen. The side chains of lysine and arginine contribute to the positively charged surface by their
nitrogen-containing amino groups.

expression at the mRNA level remained similar in all samples
with different levels of GRE-HA expression (Fig. 3C), as verified
by quantitative real-time PCR using a Myc-tag specific primer
and a protocol published previously (19). This excludes the possibility that changes in mature Myc-BMP4 in the CM are due to
differences in BMP4 gene expression.
Gremlin DAN Domain Is Essential to Mediate GremlinBMP4 Interaction—The activity of BMP4 is thought to be precisely regulated extracellularly by many molecules defined as
BMP antagonists (9), which have a cystine-knot structure similar to BMPs themselves. DAN family proteins are one subgroup of BMP antagonists with a conserved eight-cystine membered knot structure on their carboxyl terminus, which
distinguish them from other BMP antagonists with a nine or
10-membered cystine ring (20). The DAN family includes
Gremlin (14, 12), PRDC (21), coco (22), Cer1 (homologue of
Xenopus Cerberus (10), DAN (23), USAG-1 (24), and sclerostin
(25, 26), which are able to directly interact with BMPs and prevent BMPs from binding to their receptors. However, the
molecular mechanisms of their protein interaction have never
been explored. To further determine the specificity of BMP4Gremlin binding and the molecular motif in Gremlin that is
responsible for this intermolecular interaction, two Gremlin
mutant molecules, GRE-DAN-HA and GRE-NF-HA, were generated with truncation of the NH2-terminal fragment or the
carboxyl-terminal DAN domain, respectively (Fig. 4). Removal
of the DAN domain from the Gremlin molecule (GRE-NF-HA)
fully abolished its BMP4 binding ability and resulted in rapid
and increased secretion of this truncated Gremlin molecule
into the CM. In contrast, deletion of the N-terminal fragment of
Gremlin did not have any impact on its BMP4 binding ability.
Most of the GRE-HA and GRE-DAN-HA proteins with BMP
binding activity were retained in the cell lysates. This suggests
that the DAN domain in Gremlin is essential for BMP4 binding
and that intracellular BMP4 precursor-Gremlin protein complex is not secreted outside the cell.
Mapping the BMP4 Binding Motif of Gremlin DAN Domain—
Not all the proteins with a highly conserved eight-membered
Cys-knot DAN domain homology are able to bind to BMP4 or
other BMPs. One of these proteins is Mucin-2 (Fig. 5A).
Replacement of the Gremlin DAN domain with the corresponding Mucin-2 DAN domain sequence fully eliminated
both its BMP4 binding activity and its BMP4 inhibitory function (GRE-Muc-HA in Figs. 3 & 5, B–D). To further determine
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the protein sequence motif of Gremlin DAN domain that is
responsible for BMP4 interaction, we made a variety of Gremlin-Mucin-2 chimeras within the DAN domain region without
changing its Cys-knot structure (Fig. 5B). These Gremlin-Mucin-2 chimeric proteins were coexpressed with Myc-BMP4 in
COS-1 cells by transient transfection. The related BMP4 binding
and inhibitory activities were evaluated by co-immunoprecipitation and BMP4-stimulated C2C12 cell differentiation assay. Thus,
a 30-amino acid region corresponding to Gremlin amino acid
sequence 145–174 (PKKFTTMMVTLNCPELQPPTKKKRVTRVKQ) appears essential to mediate the interaction between Gremlin and BMP4 and its BMP4 inhibitory effect (Fig. 5, B–D). Next,
the function of this molecular motif in mediating the interaction
between Gremlin and mature BMP4, which is the mechanism of
Gremlin antagonistic effect on active BMP4, was tested in the
BMP4-induced C2C12 cell differentiation assay. Interestingly,
preincubation of active BMP4 (100 ng/ml) with a synthesized
linear peptide corresponding to the mapped amino acid
sequences (145–174, 0.5 M) significantly inhibited BMP4
activity by 56 ⫾ 10% ( p ⬍ 0.05, Fig. 5E), similar to the BMP4
inhibitory effect obtained by preincubation with full-length
Gremlin in the CM (35 ⫾ 3% inhibition in Fig. 5E). Meanwhile,
a control peptide with the amino acid sequence of Gremlin
NH2-terminal fragment (37–52) at the same concentration (0.5
M) did not display any inhibitory effect on BMP4 signaling
activity.
An approximate structure of mouse Gremlin DAN domain
(amino acid 94 –184; CKTQP . . . SIDLD) was then determined
with respect to the published structure of human chorionic
gonadotropin chain B by homology modeling using the program Modeler version 8.1 (Fig. 6; Refs. 27 and 28). As previously
delineated by Avsian-Kretchmer and Hsueh (20), human chorionic gonadotropin chain B is a good homology modeling template for Gremlin because they both share cystine knots that
form eight-membered rings and have “fingers” of similar size.
The mapped 30-amino acid region (145–174) spans across a
whole finger structure (finger 2), which provides a surface that
is independent of the rest of the molecule. In addition, the most
dominant feature of finger 2 in Gremlin DAN domain appears
to be the positively charged lysine and arginine residue side
chains spread across the surface, suggesting that this positively
charged surface might bind to the negatively charged patch
(residues of aspartic acid and glutamic acid) that has been
observed on carboxyl-terminal BMP2/4.
VOLUME 281 • NUMBER 39 • SEPTEMBER 29, 2006
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DISCUSSION
Our studies indicate that inhibition of BMP4 activity can be
achieved either by intracellular interaction with Gremlin when
coexpressed in the same cells or by an extracellular antagonistic
mechanism if Gremlin is expressed in different cells. The intracellular interaction and subsequent inhibition of BMP4 secretion by Gremlin may provide an efficient and fine regulatory
mechanism to direct different cellular fates by changing autocrine/paracrine activity in neighboring cells within a small
microenvironment or may provide a negative feed back mechanism for certain cells. The intracellular interaction between
Gremlin and BMP4 appeared to be tissue-specific, as detected
in embryonic lung, but not in embryonic kidney. Thus, Gremlin
and BMP4 may not coexpress in the same cells in kidney at this
specific stage. Alternatively, BMP family members other than
BMP4 may bind to Gremlin in kidney, or BMP antagonists
other than DAN family proteins, such as CRIM1 (29), may be
the major players in regulating BMP signaling activity in kidney
and other tissues.
As reported previously, cleavage of BMP4 precursor into the
mature form of BMP4 occurs in the trans-Golgi network (7).
Co-immunoprecipitation of Gremlin with the precursor form
of BMP4 in cells co-transfected with Gremlin and BMP4 suggests that the intracellular protein interaction between BMP4
and Gremlin occurs in the subcellular compartments before
these proteins enter the trans-Golgi network during the secretion process (co-translational or endoplasmic reticulum sites).
Binding of Gremlin appears to affect the processing of precursor to mature BMP4 in cells and subsequently inhibit BMP4
secretion. This could be a most efficient and rapid way to downregulate BMP4-mediated signal activity in cells. However, the
exact physiological roles of this intracellular Gremlin regulatory function versus extracellular antagonistic function in vivo
needs to be further investigated.
The intracellular inhibition of BMP4 by Gremlin interaction
also implies that measurement of BMP4 ligand mRNA expression level alone by RT-PCR and/or in situ hybridization, which
are commonly used to evaluate BMP4 activity in developmental
biology studies, may not reflect the actual BMP4 activity, since
that approach neglects the important posttranslational processing of the BMP4 precursor protein regulated by Gremlin.
Whether this intracellular inhibitory effect of Gremlin is a common mechanism to all DAN family proteins remains to be
determined. van Bezooijen et al. (30) reported that sclerosteosis
resulting from a defective sclerostin did not occur via a classical
BMP antagonistic mechanism, since addition of exogenous
sclerostin into mouse C2C12 cell culture medium did not
antagonize BMP-stimulated ALP activity. Based upon our data,
an intracellular BMP inhibitory effect may well mediate the
biological effect of sclerostin. This novel intracellular GremlinBMP4 precursor interaction may therefore help us to more precisely understand the regulation of BMP signaling mechanisms
in physiological as well as pathological situations.
By replacing Gremlin DAN domain with the corresponding
Mucin-2 DAN domain protein sequences, the BMP4 binding
and inhibitory activity of Gremlin is fully abolished, confirming
the specificity of intracellular Gremlin-BMP4 interaction. FurSEPTEMBER 29, 2006 • VOLUME 281 • NUMBER 39

thermore, a 30-amino acid peptide motif in Gremlin DAN
domain was mapped by introducing a variety of mutations in
the protein sequences of Gremlin DAN domain without disruption of the overall Cys-knot structure. From molecular
modeling, we speculate that these 30-amino acid residues constitute an independent surface finger structure with multiple
positively charged lysine and arginine residues, providing a
docking site for negatively charged patch on BMP ligands.
Thus, BMP4 inhibition by Gremlin-BMP4 interaction may be
mediated by a mechanism that is different from other nonDAN family antagonist-mediated BMP inhibition, such as Noggin (31). Noggin-BMP7 binding is mediated by hydrophobic
interaction that masks the hydrophobic interface required for
BMP receptor I and II binding (31, 32). Alternatively, GremlinBMP4 interaction could result in BMP4 conformational
changes, which prevents BMP4 precursor cleavage and maturation within the cell, and reduces BMP4-receptor binding
activity outside the cell.
Acknowledgment—We thank Sue Buckley for critically reading the
manuscript.
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